About MedPrime Technologies
MedPrime Technologies is a company based in Thane (India) founded in 2014 by Samrat Singh, Mahesh Kumar Rathor, Greeshma Unnikrishnan, and Binil Jacob. MedPrime Technologies has raised $1.71 million across 7 funding rounds from investors including Mumbai Angels, Wellfound and ACT Grants. The company has 21 employees as of April 07, 2024. MedPrime Technologies offers products and services including Cilika and Micalys.
- Headquarter Thane, India
- Employees 21 as on 07 Apr, 2024
- Founders Samrat Singh, Mahesh Kumar Rathor, Greeshma Unnikrishnan, Binil Jacob
- Stage Minicorn
-
Sectors
HealthcareIndustrial Goods & Manufacturing
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Medprime Technologies Private Limited
- Date of Incorporation 26 Nov, 2014
- Jurisdiction Thane, Maharashtra, India
-
Annual Revenue
$229.8 K (USD)116.13as on Mar 31, 2022
-
Net Profit
-$52.2 K (USD)-233.68as on Mar 31, 2022
-
EBITDA
-$72.86 K (USD)-451.05as on Mar 31, 2022
-
Total Equity Funding
$1.71 M (USD)
in 7 rounds
-
Latest Funding Round
$1.31 M (USD), Seed
Sep 18, 2024
-
Investors
Mumbai Angels
& 22 more
-
Employee Count
21
as on Apr 07, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of MedPrime Technologies
MedPrime Technologies offers a comprehensive portfolio of products and services, including Cilika and Micalys.
Microscope for pathology teaching and demonstrations with image capture.
AI-integrated tool for transforming pathology diagnostics and disease detection.
Funding Insights of MedPrime Technologies
MedPrime Technologies has successfully raised a total of $1.71M across 7 strategic funding rounds. The most recent funding activity was a Seed round of $1.31 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in MedPrime Technologies
MedPrime Technologies has secured backing from 23 investors, including venture fund, angel, and institutional investors. Prominent investors backing the company include Mumbai Angels, Wellfound and ACT Grants.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Locked | Locked | Locked | |
|
Sustainable startups are supported via innovation curation and venture funding.
|
Locked | Locked | Locked | |
|
Seed capital grants are provided to incubate and accelerate innovations.
|
Locked | Locked | Locked |
Investor details for MedPrime Technologies
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by MedPrime Technologies
Investment portfolio details for MedPrime Technologies
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - MedPrime Technologies
Detailed financials for MedPrime Technologies
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Medprime Technologies Comparisons
Peer comparison for MedPrime Technologies
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of MedPrime Technologies
Detailed competitors of MedPrime Technologies
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Medprime Technologies
Complete news archive for MedPrime Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MedPrime Technologies
MedPrime Technologies was founded in 2014 and raised its 1st funding round 1 year after it was founded.
MedPrime Technologies is headquartered in Thane, India. It is registered at Thane, Maharashtra, India.
Samrat Singh is the current CEO of MedPrime Technologies. They have also founded this company.
MedPrime Technologies is a funded company, having raised a total of $1.71M across 7 funding rounds to date.
As of Apr 07, 2024, the latest employee count at MedPrime Technologies is 21.
Annual revenue of MedPrime Technologies is $229.8K as on Mar 31, 2022.
MedPrime Technologies was founded in 2014 in Thane, India, within the medical technology sector. Digital microscope systems are designed and manufactured to support pathology and telepathology applications. Image clarity is enhanced, remote consultations are enabled, and workflows are streamlined for pathology practices. Diagnostic accuracy and efficiency are thereby improved. Product support and maintenance services are offered to clients.
MedPrime Technologies offers Cilika and Micalys.
MedPrime Technologies has 23 investors. Key investors include Mumbai Angels, Wellfound, ACT Grants, Lavni Ventures, and Keiretsu Forum.
The valuation of MedPrime Technologies is $5.98M as of Sep 2024.